1,2-Oxazino[6,5-b]indol-6-ol,2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-, (4aS,9aS)- (123871-10-3)

Identification
Name:	1,2-Oxazino[6,5-b]indol-6-ol,2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-, (4aS,9aS)-
Synonyms:	1,2-Oxazino[6,5-b]indol-6-ol,2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-, (4aS-cis)-; (-)-Geneseroline;Geneseroline
CAS:	123871-10-3
Molecular Formula:	C13H18 N2 O2
Molecular Weight:	0
InChI:	InChI=1/C13H18N2O2/c1-13-6-7-14(2)17-12(13)15(3)11-5-4-9(16)8-10(11)13/h4-5,8,12,16H,6-7H2,1-3H3/t12-,13-/m0/s1
Molecular Structure:
Properties
Flash Point:	188.4°C
Boiling Point:	387.8°Cat760mmHg
Density:	1.19g/cm³
Refractive index:	1.582
Flash Point:	188.4°C
Safety Data

Other Product

Carbamic acid,N-(2-methylphenyl)-,(4aS,9aS)-2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-1,2-oxazino[6,5-b]indol-6-ylester, hydrochloride (1:1)
1,2-Oxazino[6,5-b]indole,7-bromo-2,3,4,4a,9,9a-hexahydro-2-methyl-4a,9-bis(3-methyl-2-buten-1-yl)-,(4aS,9aS)-
1,2-Oxazino[6,5-b]indol-6-ol,2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-, 6-(N-methylcarbamate), (4aS,9aS)-
N-(2-Ethylphenyl)carbamic acid (4aS,9aS)-2,4a,9-trimethyl-2,3,4,4a,9,9a-hexahydro[1,2]oxazino[6,5-b]indol-6-yl ester hydrochloride
Carbamic acid,N-(3-methylphenyl)-,(4aS,9aS)-2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-1,2-oxazino[6,5-b]indol-6-ylester, hydrochloride (1:1)
Carbamic acid, heptyl-,(4aS,9aS)-2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-1,2-oxazino[6,5-b]indol-6-ylester (9CI)
Carbamic acid,N-heptyl-,(4aS,9aS)-2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-1,2-oxazino[6,5-b]indol-6-ylester, hydrochloride (1:1)
1H-Pyrano[3,4-d]oxepin-4-carboxylicacid,9-[2-(3,4-dihydroxyphenyl)ethoxy]-4a,5,6,8,9,9a-hexahydro-1-hydroxy-6-oxo-,2-(3,4-dihydroxyphenyl)ethyl ester, (1R,4aS,9S,9aS)-
1H-Pyrano[3,4-d]oxepin-4-carboxylicacid, 4a,5,6,8,9,9a-hexahydro-1-hydroxy-9-[2-(4-hydroxyphenyl)ethoxy]-6-oxo-,methyl ester, (1R,4aS,9S,9aS)-rel-(+)-
(4aS,9aS)-5-amino-8-[(2-methoxy-5-methylphenyl)amino]-6-(trihydroxy-lambda~4~-sulfanyl)-4a,9a-dihydroanthracene-9,10-dione
L-Glutamic acid, hydrochloride, mixt. with (4aS-cis)-2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-1,2-oxazino(6,5-b)indol-6-yl methylcarbamate mono(2-hydroxybenzoate) and papain
5-oxo-L-proline, compound with (4aS-cis)-2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-1,2-oxazino[6,5-b]indol-6-yl methylcarbamate (1:1)
2-Propenoic acid,3-(methylthio)-,(3R,3aR,4S,- 4aS,5R,6S,8aR,9aR)-decahydro-4-methoxy-3,- 4a,5-trimethyl-1-oxo-3a,9a-epoxynaphtho[2,- 3-b]furan-6-yl ester,(2Z)-
1H-Pyrano[3,4-d]oxepin-4-carboxylicacid, 4a,5,6,8,9,9a-hexahydro-1-hydroxy-9-[2-(4-hydroxyphenyl)ethoxy]-6-oxo-,2-(3,4-dihydroxyphenyl)ethyl ester, (1R,4aS,9S,9aS)-rel-(+)-
1H-?4,?6,?9a-?(Epoxymetheno)?-?2-?oxacycloocta[cd]?pentalen-?1-?one, 2a,?3,?4α,?4a,?5,?7,?8,?9,?10β,?10β-?decahydro-?2aα,?3β,?4a,?9β-?tetrahydroxy-?5α,?9-?dimethyl-?, 9-?acetate 3-?methanesulfonate (8CI)
9H-Xanthen-9-one,1,2,3,4,4a,9a-hexahydro-1,4,8,9a-tetrahydroxy-4a,6-dimethyl-, (1S,4S,4aS,9aR)-
(4R,4aS,6R,7R,7aR,12bS)-3-(cyclopropylmethyl)-6-(2-hydroxypropan-2-yl)-9-methoxy-1,2,3,4,5,6-hexahydro-4a,7-ethano-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-ol
Spiro[1H-7,9a-methanocyclohepta[c]pyran-4(3H),1'-[3]cyclohexene]-6'-carboxaldehyde,9-(acetyloxy)-4a,5,6,7,8,9-hexahydro-5',5'-dimethyl-8-methylene-1,2'-dioxo-,(1'S,4aS,6'R,7R,9R,9aS)-
salicylic acid, compound with (4aS-cis)-2,3,4,4a,9,9a-hexahydro-2,4a,9-trimethyl-1,2-oxazino[6,5-b]indol-6-yl methylcarbamate (1:1)
(3'Z)-3'-ethylidene-6-hydroxy-1-methoxy-1'-methyl-1',2',3',4',4a',5',9',9a'-octahydro-7'H-spiro[indole-3,8'-[4,7]methanooxepino[4,3-b]pyridin]-2(1H)-one